Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
The medical journal Neurology has reported that people who carry a gene that's associated with Alzheimer's disease may lose their sense of smell long before memory and thinking problems occur.
The specific gene reported in this paper is called APOE e4.
You can order APOE Alzheimer's Risk from Labcorp. The code is: 504040
Testing a person's ability to detect odors may be a useful way to predict future problems with cognition.
The study from the Neurology journal surveyed more than 865 people about their ability to detect an odor and identify what they were smelling. Tests were given over five years. Those with memory or thinking problems were tested twice, five years apart. The investigators also took DNA samples.
People who carried the gene variant (APOE e4) for Alzheimer's were 37% less likely to have good odor detection than people without the gene, the researchers found.
Those with the gene (APOE e4) experienced reduced smell detection from age 65 to 69.
People with the gene variant (APOE e4) did not show a difference in the ability to identify what they were smelling until ages 75 to 79. Once the ability to identify odors declined, it declined faster than in those who did not carry the gene.
At the start of the study, thinking and memory skills were similar among the two groups.
Unfortunately, the researchers concluded that thinking skills declined more rapidly among those carrying the gene variant than among those without the gene.
You can find a qualified and certified functional medicine practitioner by going to: www.FunctionalMedicineDoctors.com
References:
https://www.nia.nih.gov/news/loss-smell-linked-alzheimers-cognitive-impairment-and-biomarkers
https://practicalneurology.com/news/loss-of-smell-may-predict-alzheimer-disease-and-dementia
https://jnnp.bmj.com/content/70/6/739
https://news.uchicago.edu/story/rapid-loss-smell-predicts-dementia-and-smaller-brain-areas-linked-alzheimers
Compliments from Functional Medicine University www.FunctionalMedicineUniversity.com
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
I have always had a strong foundational belief that when your gut is well your overall health is well.
New studies are beginning to see a distinct correlation between poor gut health especially chronic constipation and early dementia.
Chronic constipation may not only be an indicator of gut health, but a potential warning sign of cognitive decline.
Researchers found that among more than 110,000 middle-aged and older U.S. adults, those who were chronically constipated who had fewer than three bowel movements a week showed early signs of poor brain health.
The findings presented at a meeting of the Alzheimer's Association in Amsterdam showed that people with chronic constipation typically performed worse on tests of memory and thinking,
In addition, 73% of these same people stated that were more likely to say their cognitive skills were waning.
Although the study is strictly preliminary and did not absolutely prove that constipation caused the aging brain to deteriorate faster, the researchers of this study do believe there is evidence connecting gut health to brain health.
The researchers theorize that constipation and cognition are linked via the gut microbiome.
The science is exploding with research linking abnormal gut microbiome and various diseases, including degenerative brain diseases like Alzheimer's.
Claire Sexton, senior director of scientific programs and outreach for the Alzheimer's Association stated the it is unclear at this point whether constipation itself or the underlying cause of constipation,that being disruptions in the gut microbiome, is driving this association.
Dr. Dong Wang of Brigham and Women's Hospital and Harvard Medical School and the senior researcher on the study stressed the importance of clinicians discussing gut health, especially constipation, with their older patients.
Of special interest the researched found that people with constipation and worse cognition tended to have relatively few gut bacteria that produced butyrate -- an important fatty acid that helps control inflammation.
I strongly would encourage any and all people suffering with chronic constipation to have a functional medicine or integrative practitioner to do deep dive into their gut health via a comprehensive stool test.
I say why wait for science to catch up with may indeed be a potential connection between compromised gut health poor cognition.
I recommend finding a healthcare practitioner who can order one of the following excellent stool tests:
GI Effects--https://www.gdx.net/products/gi-effects
Gut Zoomer-https://www.vibrant-wellness.com/test/GutZoomer
GI 360-https://www.doctorsdata.com/GI360-stool
With the results obtained from any of the above stool tests you will have deep window into your gut health and understand what steps you can take to address any potential issues found on the test.
The question remains: Can improved gut health have a positive impact in improved cognitive health?
To be quite honest, I tend to lean toward an affirmative yes and would not risk having a disease as serious as dementia take hold of any patient without at least testing the waters and see if one's cognitive health improves with improved gut health.
You can find a qualified and certified functional medicine practitioner by going to: www.FunctionalMedicineDoctors.com
Reference
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730313/
https://www.cnn.com/2023/07/19/health/constipation-cognitive-decline-gut-health-wellness/index.html
https://www.frontiersin.org/articles/10.3389/fnins.2021.821654/full
https://www.wavy.com/news/health/chronic-constipation-may-lead-to-dementia/
https://www.nature.com/articles/s41531-021-00191-w
https://www.newscientist.com/article/2383117-chronic-constipation-is-associated-with-cognitive-decline/
https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-020-01644-2
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286902/
Compliments from Functional Medicine University www.FunctionalMedicineUniversity.com
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
Here is yet another reason to be super compliant in taking care of your teeth and that is for the prevention of dementia.
A study published in the Journal of Neuroinflammation has found that periodontal (gum) disease leads to changes in your brain's microglial cells.
What is the function of the microglial cells in the brain?
Microglia can be generated from white blood cells known as monocytes that circulate in the blood and are responsible for the elimination of microbes, dead cells, redundant synapses, protein aggregates, and other particulate and soluble antigens that may endanger the Central Nervous System
These are white blood cells that defend the brain from amyloid plaque that is associated with cognitive decline.
Unfortunately, when a person has gum disease microglial cells stop being able to digest amyloid plaque leading to neuro-inflammation in the brain.
Further studies convincingly revealed similar conclusions:
A study performed by the NIA Intramural Research Program team using publicly available data from the National Health and Nutrition Examination Survey (NHANES), a large population study performed by the CDC's National Center for Health Statistics examined whether gum disease and infections with oral bacteria were linked to dementia diagnoses and deaths.
The team compared different age groups at baseline, with up to 26 years of follow-up, for more than 6,000 participants.
The NHANES participants received a dental exam for signs of gum disease and a high percentage were found to have the bacteria, Porphyromonas gingivalis
This is the most common culprit of gum disease. In addition a study revealed that plaques of beta-amyloid protein, a major hallmark of Alzheimer's disease, may be produced as a response to Porphyromonas gingivalis.
The study further revealed that older adults with signs of gum disease and mouth infections at baseline were more likely to develop Alzheimer's during the study period. Among those 65 years or older, both Alzheimer's diagnoses and deaths were associated with antibodies against the oral bacterium Porphyromonas gingivalis.
Almost half of Americans 30 and older have periodontal disease, according to the Centers for Disease and Prevention.
The number of Americans with Alzheimer's is predicted to more than double by 2050.
Could periodontal disease be an underlying contributing factor?
Maybe and to be quite honest emerging studies tend to lean toward this relationship and worth taken serious by all concerned about developing dementia
Steps to take to decrease the potential of developing dementia should include the following as it relates to dental care:
** Always consult with a physician or healthcare practitioner with significant integrative or functional medicine training.
You can find a qualified and certified functional medicine practitioner by going to: www.FunctionalMedicineDoctors.com
References
https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-023-02821-x
https://www.nia.nih.gov/news/large-study-links-gum-disease-dementia
https://now.tufts.edu/2022/07/11/studying-link-between-gum-disease-and-alzheimers-disease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4488989/
https://www.nyu.edu/about/news-publications/news/2021/april/gum-bacteria-alzheimers.html
https://forsyth.org/gum-disease-linked-to-buildup-of-alzheimers-plaque-formation/
https://www.alzheimers.org.uk/research/care-and-cure-research-magazine/gum-disease-link-faster-decline-alzheimers
https://www.sciencedirect.com/science/article/pii/S277255962200027X
https://link.springer.com/article/10.1007/s40496-022-00319-8
Compliments of Functional Medicine University
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
In a peer reviewed human study, a magnesium compound has been shown to reverse markers of brain aging by as much as 14 years!
This finding by Massachusetts Institute of Technology (MIT) researchers shows that the unique magnesium-L-threonate concentrates in the brain to rebuild neuronal connections and youthful brain plasticity.
Scientists have shown that magnesium plays an essential role in supporting brain plasticity.
Brain plasticity is the sign of a youthful, flexible brain primed for optimal learning, memory, and cognitive function in a rat animal model.
A medical study showed raising brain magnesium levels has been proven to restore important brain plasticity thereby leading to improved cognitive function.
Scientists at MIT developed and tested a special compound called magnesium-L-threonate and found it boosted brain magnesium levels by an approximately 15%.
These scientists found a novel way of overcoming the problem of getting magnesium loaded into the brain due to poor absorption via using magnesium-L-threonate.
Compared to other various forms of magnesium, they found that magnesium-L-threonate had the highest brain magnesium-loading ability and has been shown to cross the blood-brain barrier readily and coincide with improvements in cognitive function.
In conclusion, studies show that magnesium-L-threonate improves brain plasticity, leading to significant improvements in memory, learning, and control of emotions.
References
https://pubmed.ncbi.nlm.nih.gov/20152124/
https://pubmed.ncbi.nlm.nih.gov/22016520/
https://pubmed.ncbi.nlm.nih.gov/26519439/
https://www.drperlmutter.com/magnesium-threonate-powers-brain/
Compliments of www.functionalmedicineuniversity.com
Ronald Grisanti D.C., DABCO, DACBN, MS, CFMP
Mercury toxicity is the great mimicker of a host of health challenges.
Here is a sample of what one should know about mercury toxicity.
1: Mercury is known to denervate nerve fibers, similar to the pathology of multiple sclerosis. In other words it makes it so the nerves do not work.
2: Mercury can leak into the blood-brain barrier and reduce nerve conduction velocity and visual evoked responses, diagnostic tests used for multiple sclerosis.
3: Mercury can inhibit the action (binding) of happy hormones, like serotonin, at the synapse (nerve to nerve connection) leading to depression.
4: Mercury can cause hearing loss.
5: Mercury can decrease norepinephrine and dopamine activity at synapses, damaging our molecules of emotion. This can make a person lack zip, enthusiasm, joy, and creativity and make him anxious, insomniac, and terribly tense.
6: Mercury can create peripheral neuropathy, auto-immunity and interferes with synapse transmission, decreasing infection control so the unsuspecting victim gets recurrent sinusitis, prostate or gum infections, as examples.
7: Hidden mercury toxicity can be at the root of a resistant Candida infection. Sometimes you just cannot clear Candida symptoms until you get rid of the mercury.
8: Mercury is also a major undiagnosed cause of chronic fatigue and fibromyalgia.
9: Whenever we see someone resistant to all treatments, there is a high probability mercury toxicity is at the root of it.
10: Mercury toxicity can create any baffling neurologic disease as well as impair cure for any disease of other body systems.
One of the most common symptoms we see from mercury toxicity is that of terrible body burning and baffling pain that migrates.
But what neurologist looks for mercury toxicity?
And you certainly will never find it by doing an MRI.
Instead, folks get fictitious diagnoses like erythromelalgia, fibromyalgia, idiopathic neuropathy, neurosis, idiopathic pain syndrome, or hypochondriasis.
Reference:
Rogers SA, Detoxify or Die, Prestige Publishing, Syracuse NY, 2002
Compliments from Functional Medicine University www.FunctionalMedicineUniversity.com
Ronald Grisanti D.C., D.A.B.C.O., D.A.C.B.N., M.S., CFMP
Multiple Sclerosis (MS) is a serious chronic neurological disorder in which the insulating cover of nerve cells (myelin sheathing) is destroyed. This is referred to as demyelination.
As of 2008, between 2 and 2.5 million people are affected globally
As the disease progresses, the nerves malfunction leading to an inflammatory cascade that damages the brain and spinal cord (CNS).
Four common symptoms of MS include:
Eye pain
Numbness, tingling, or a pins-and-needles sensation anywhere in the body that doesn't go away after two weeks
Swelling of the limbs or trunk
Intense itching sensation, especially in the neck area
There are four types of MS.
1: Relapsing-remitting MS- this is where a person will have a period of symptoms followed with a period where there will be no symptoms.This is the most common type of MS.
Unfortunately, the next three are progressive and symptoms tend to not go away.
2: Primary progressive—this is associated with the disease being progressive with no remission.
3: Secondary progressive—this is associated with initially having remissions followed with progressive deterioration and more remissions.
4: Progressive relapsing—this is associated with an initial progressive onset where there were no remissions. However, later as the disease progresses a person may experience remissions.
Diagnosis
Unfortunately there are no specific antibody tests for MS. The disease is confirmed “only” after the person has neurological symptoms twice and lesions are found on an MRI. It is important to note that one episode of the common symptoms that resolve and never come back is considered negative for MS.
Triggering Theory
Scientists in the field of immunology have been searching for the potential “triggers” that cause the immune cells to attack the myelin sheathing.
Scientists have posed the question, “is something damaging the insulation of nerve cells”? The literature including functional medicine practitioners has supported a few triggers such as gluten, Epstein Barr, vitamin D deficiency, heavy metals toxicity and microbial pathogens.
Today we will spend a little time on the issue of infectious disease as a potential trigger of MS.
The medical research has identified elevated amounts of immunogobulins in 95 percent of MS patients. This suggests that the brain is aggressively battling an infection.
It is interesting to note that the pathogen most commonly involved in this fight infecting the brain is Chlamydia pneumonia.
Researchers from the Department of Neurology at Vanderbilt University School of Medicine have found that 50% of C. pneumoniae are also made inside the central nervous system as well as the brain.
Further studies have revealed enthusiastically that the eradication of Chlamydia pneumonia via the antibiotic, minocycline helped improve the symptoms of rapidly worsening MS patients
References:
Contini C1, Seraceni S, Cultrera R, Castellazzi M, Granieri E, Fainardi E. Chlamydophila pneumoniae Infection and Its Role in Neurological Disorders. Interdiscip Perspect Infect Dis. 2010
Chen X1, Ma X, Jiang Y, Pi R, Liu Y, Ma L. The prospects of minocycline in multiple sclerosis. J Neuroimmunol. 2011 Jun;235(1-2)
Fainardi E1, Castellazzi M, Tamborino C, Seraceni S, Tola MR, Granieri E, Contini C. Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms. J Neurovirol. 2009 Sep;15(5-6):425-33.
Szczucilski A1, Losy J. Infectious agents in the pathogenesis of multiple sclerosis. Przegl Epidemiol. 2006;60 Suppl 1:160-5.
Compliments from Functional Medicine University www.FunctionalMedicineUniversity.com
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
Emerging evidence between depression, anxiety, and exposure to mold has surfaced. It is thought to be associated with many complex health problems. Black mold species such as Aspergillus, Fusarium and Stachybotrys produce mycotoxins that are toxic to central parts of the body, including the brain.
Many mycotoxins are neurotoxins causing lesions in the brain in the grey matter and the white matter. This directly affects the frontal cortex, cause dopamine dysfunction which can create psychological disorders like anxiety or depression. These disorders occurs when the nerve cells in the brain that make dopamine are slowly destroyed. Without dopamine, the nerve cells in that part of the brain cannot properly send messages.
Mold is a biotoxin, and it releases toxic gas and spores into the air. When the toxins enter your body, via skin or air, the toxic gases cause a disturbance in many organs, including your brain.
Brown University conducted a series of cases linking mold, anxiety, and depression back in 2007. This was a large study, analyzing data from 5,882 adults in 2,982 households. Molds are toxins, and some research has indicated that these toxins can affect the nervous system or the immune system or impede the function of the frontal cortex.
Mold spores act as irritants, which can trigger the body to mount an immune response. This can lead to inflammation throughout the body. Inflammation in the brain can impair cognitive function, and in the case of chronic inflammation, this can lead to long-lasting cognitive impairment.
Mold is a sometimes silent and yet formidable trigger of symptoms. It is lurking in our homes, offices, cars, washing machines, and bathrooms without notice. It is quite literally a silent but deadly killer of our immune system and trigger of brain-related issues. If you have been exposed, you must detox mold from your body as soon as possible.
One of the best test to detect mycotoxins is from Great Plains Laboratory (https://www.greatplainslaboratory.com/gpl-tox)
Here is a sample report from Great Plains Laboratory--https://www.functionalmedicineuniversity.com/GPLTOXReport.pdf
If you find you have mold (mycotoxin) exposure it is recommended to consult with your physician for the best treatment.
It is also imperative to do a deep dive into your home or work environment to identify where the mold is coming from. If mold is discovered the next step is to hire a professional company do a mold remediation.
References:
https://news.brown.edu/articles/2007/08/depression-and-household-mold
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179161
https://www.clinicaltherapeutics.com/article/S0149-2918
Compliments of www.functionalmedicineuniversity.com
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
A study from the journal Neurology revealed that nonalcoholic fatty liver disease (NAFLD) is independently associated with cognitive impairment.
Nonalcoholic fatty liver disease (NAFLD) is an umbrella term for a range of liver conditions affecting people who drink little to no alcohol. As the name implies, the main characteristic of NAFLD is too much fat stored in liver cells.
Dementia and NAFLD are two frequent conditions that share underlying risk factors mainly in the realm of metabolic disease.
The study from the journal, Neurology, included 4,472 adults aged 20–59 years.
The participants underwent assessment of liver enzyme activity and hepatic steatosis by ultrasound, and underwent cognitive evaluation using the following computer-administered tests: the Simple Reaction Time Test (SRTT), the Symbol-Digit Substitution Test (SDST), and the Serial Digit Learning Test (SDLT).
Increased activity of the liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) correlated with lower performance on the SDLT, while increased alanine aminotransferase was also correlated with lower performance in the SDST.
The current studies suggest that NAFLD patients incur cognitive dysfunction.
Although if left untreated NAFLD can lead to much more serious conditions including cirrhosis and liver failure. The good news is that fatty liver disease can be reversed—and even cured.
8 Steps to Effectively Treat Fatty Liver Disease
1. Lose excess weight--losing between 7 and 10 percent of body weight can improve other symptoms of NAFLD, such as inflammation, fibrosis, and scarring
2: Research from 2017 suggests that the Mediterranean diet may help to reduce liver fat, even without weight loss.
3: Exercise: It's important to stay active when you have NAFLD. A good goal to shoot for is at least 150 minutes of moderate-intensity exercise per week.
4: Avoid foods with added sugars-Dietary sugars such as fructose and sucrose have been linked to the development of NAFLD.
5: Take an omega-3 supplement--A peer review study suggests that taking an omega-3 supplement may reduce liver fat.
6: Avoid known liver irritants--Certain substances can put excess stress on your liver. They include alcohol and certain over the counter medications.
7: Consider taking vitamin E--Vitamin E is one antioxidant that may reduce inflammation caused by NAFLD. Must take all components of vitamin E. This would include Mixed Tocopherols and Tocotrienols
8: Consider Herbs--A 2018 paper identified certain herbs, supplements, and spices that have been used as alternative treatments for NAFLD. Compounds shown to have positive effects on liver health include turmeric, milk thistle, resveratrol, and green tea.
References
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4820136/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400092/
https://aasldpubs.onlinelibrary.wiley.com/doi/pdf/10.1002/hep.22752
https://www.hindawi.com/journals/grp/2016/1459790/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789322/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6165515/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960814/
Compliments from Functional Medicine University www.FunctionalMedicineUniversity.com
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
A recent study in Nature Communications suggests that Parkinson's disease may actually start in the gut.
The microbiota-gut-brain axis has been suggested to play an important role in Parkinson's disease (PD)
Parkinson's is a brain disorder that can cause uncontrollable movements such as shaking, limb stiffness, and difficulty with balance and coordination.
The study published in Nature Communications involved recruiting 490 people with Parkinson's and 234 individuals who were neurologically healthy.
Each provided a stool sample and information about themselves.
When samples were analyzed, researchers found that bacteria, genes, and biological pathways differed by more than 30% in those with Parkinson's compared to those who were neurologically healthy.
Of special interest was the fact that a specific bacterial species called Bifidobacterium dentium commonly known to cause infections such as brain abscesses, was seven times higher in folks with Parkinson's
On the other hand another bacteria called Roseburia intestinalis commonly found in healthy colons, was 7.5 times lower.
I recommend ordering the Gut Zoomer Stool Test from Vibrant Wellness. https://www.vibrant-wellness.com/test/GutZoomer
Here is a sample report which includes both the Bifidobacterium dentium and Roseburia intestinalis
//www.functionalmedicineuniversity.com/GutZoomerSampleReport.pdf
It is important to note that constipation is a common complication of Parkinson's disease. Many people who have Parkinson's disease notice difficulties with constipation before they notice motor symptoms such as tremor or stiffness
In addition to the above mentioned bacteria, elevated levels of Escherichia coli, Klebsiella pneumonia, and quasipneumoniae have also been found in those with Parkinson's.
Although the research is in the early stages of the relationship between Parkinson's disease and gut dysfunction, it is my suggestion to consider ordering a stool test to determine if in fact the above profile is apparent and take the appropriate action steps to improve the gut microbial environment.
You simply don't know the possible positive impact this can make in moving one more step closer to improving Parkinson's disease outcomes.
References:
https://www.nature.com/articles/s41467-022-34667-x
https://www.nature.com/articles/s41467-023-38248-4
Compliments of Functional Medicine University www.FunctionalMedicineUniversity.com
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
A study in the journal Neurology explained that many who suffer with benign paroxysmal positional vertigo (BPPV) may discover that a vitamin D deficiency may be at the root of the illness.
BPPV develops when crystals in your inner ear that make you sensitive to gravity become dislodged causing that so common dizziness and nausea.
Symptoms are usually triggered by changes in your head's position when you lie down or sit up. Around 1.6% of Americans experience BPPV annually.
The most common treatments are Epley and Semont maneuvers which provide an 80% cure rate. They work by moving the troubling crystal into a more stable location.
Although the above common treatments have a high success rate, the BPPV often recurs causing disability and much frustration.
Thanks to researchers at Seoul National University College of Medicine, it has been found that taking 500 IU of vitamin D and 500 mg of calcium twice daily can reduce annual recurrence by 45% if a patient has a vitamin D blood level below 10 nanograms per milliliter, and by 14% if his or her D level is 10-20 ng/mL.
The overall prevalence rate of vitamin D deficiency was 41.6%, with the highest rate seen in blacks (82.1%), followed by Hispanics (69.2%).
We think the sedentary, indoor lifestyle of most Americans makes it more likely to have a vitamin D deficiency.
I personally like to see Vitamin D, 25-Hydroxy levels between 60 ng/ml to 80 ng/ml.
FROM SECOND OPINION PHYSICIAN
from Second Opinion Physician
If you experience ongoing or intermittent dizziness, ask your doctor about the Epley and Semont maneuvers. Then get a vitamin D blood test and start taking supplements if your level is low.
I also recommend taking vitamin D with K2.
Also do not overlook the benefits of short periods of sunlight on the skin and eye (retina). I recommend at least 15 minutes a day.
** Always consult with a physician or healthcare practitioner with significant training in nutritional, integrative and/or functional medicine before taking a new supplement.
You can find a qualified and certified functional medicine practitioner by going to: www.FunctionalMedicineDoctors.com
References
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4913711/
https://www.nature.com/articles/s41598-021-96445-x
https://pubmed.ncbi.nlm.nih.gov/35878631/
https://www.aan.com/PressRoom/Home/PressRelease/3811
https://www.frontiersin.org/articles/10.3389/fneur.2022.915239/full
https://jamanetwork.com/journals/jama/article-abstract/2772275
https://pubmed.ncbi.nlm.nih.gov/21310306/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5613455/ ;
Compliments of Functional Medicine University www.FunctionalMedicineUniversity.com
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
Excitotoxins are chemical substances that overstimulate certain types of cells in the brain, all of the nervous system, and many other organs.
In high and excessive amounts these cells become damaged and may die.
The underlying mechanism of excitotoxins has been attributed to the following diseases: Alzheimer's, parkinson's, multiple sclerosis, strokes, autism, huntington's disease.
Excitotoxins have also been found to be associated with the following diseases: migraines, diabetes, atherosclerosis, sudden death from heart disease, eye diseases, digestive disorders, autoimmune diseases, growth of tumors, spread of cancer and obesity.
The Most Common Excitotoxin is Glutamate
Glutamate is the main component of Monosodium glutamate (MSG)
As a general rule, the more a food is processed, the more likely it is to contain MSG. Foods that commonly use MSG include potato chips, flavored crackers, canned soups, dry soup mixes, canned meats, diet foods, soy sauces, salad dressings, cured meats and poultry injected with broth. But reading the labels won't always help you.
When a food product is 99 percent pure MSG it is called “monosodium glutamate” by the FDA and must be labeled as such. However, when a food product contains less than 99 percent MSG, the FDA doesn't require that the MSG be identified. So it often appears on labels in various disguised forms, such as “hydrolyzed vegetable protein,” “spices” and “natural flavoring.”
Here's a quick list of potentially suspect ingredients to watch for:
Ingredients that may contain 30 to 60 percent MSG:
hydrolyzed vegetable protein
hydrolyzed protein
hydrolyzed plant protein
plant protein extract
sodium caseinate
calcium caseinate
yeast extract
textured protein
autolyzed yeast
hydrolyzed oat flour
Ingredients that may contain 12 to 40 percent MSG:
malt extract
malt flavoring
bouillon
broth
stock
natural flavoring
natural beef or chicken flavoring
seasoning
spices
Ingredients that may contain some MSG:
carrageenan
enzymes
soy protein concentrate
soy protein isolate
whey protein concentrate
some soymilk
Although I have presented the downside of excessive glutamate it is important for me to let you know that glutamate does have positive health benefits.
These would include the following benefits:
So what is one to do when it comes to this special and sometimes detrimental neurotransmitter.
One answer is to get tested if you suspect glutamate toxicity. If your glutamate levels are high then you have an objective marker to carefully monitor as you taper and avoid foods high in glutamate.
Doctors Data Lab
If you don't want to invest in testing the next best step is to avoid foods in glutamate and see if you see an improvement in your symptoms.
Natural plant products and extracts that reduce glutamate and immunoexcitotoxicity
Curcumin, quercetin, green tea catechins, balcalein, and luteolin have been extensively studied to dampen the detrimental impact of excessive glutamate
My comments: If you suspect that your health issues are associated with glutamate toxicity I encourage you to talk with your functional medicine healthcare provider. They can best advise you on the best steps to take to improve your health.
References:
https://www.frontiersin.org/articles/10.3389/fpsyt.2018.00561/full
https://pubmed.ncbi.nlm.nih.gov/8732541/
https://pubmed.ncbi.nlm.nih.gov/10613826/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098326/
https://link.springer.com/referenceworkentry/10.1007/978-1-4614-5836-4_148
https://www.frontiersin.org/articles/10.3389/fnins.2015.00469/full
https://pubmed.ncbi.nlm.nih.gov/29859974/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7386414/
https://pubmed.ncbi.nlm.nih.gov/21288239/
https://www.nature.com/articles/srep44120
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307240/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4478437/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8977545/
https://pubmed.ncbi.nlm.nih.gov/26788243/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260594/
https://europepmc.org/article/med/27185356
The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Grisanti and his functional medicine community. Dr. Grisanti encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional. Visit www.FunctionalMedicineUniversity.com for more information on our training in functional medicine. Look for practitioners who have successfully completed the Functional Medicine University's Certification Program (CFMP) www.functionalmedicinedoctors.com. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Grisanti is required
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
Alzheimer's is the most common form of dementia. Its symptoms vary but may start with mild memory loss or difficulty remembering words or names. As it progresses, Alzheimer's causes worsening confusion and memory loss, changes in personality, the inability to perform everyday tasks and more.
Alzheimer's is caused by a slow build-up of protein plaques and tangles in the brain that eventually cause brain cells to stop working properly.
This build-up usually starts years before a person experiences symptoms. Alzheimer's-related memory loss is caused by brain cells working improperly and dying-a process known as neurodegeneration.
Alzheimer's is estimated to account for about 60% of dementia cases.
Diagnosing Alzheimer's
Until recently, it has been difficult to identify the biological changes that indicate Alzheimer's. The typical evaluation, which includes physical exam, blood and urine tests and cognitive testing may provide ambiguous or conflicting answers, which can result in delayed referrals until symptoms become clearer. That has changed with new technology and testing.
Labcorp has developed a new test called the Amyloid-Tau-Neurodegeneration (ATN) Profile (ATN Profile) to help doctors detect evidence of biological changes consistent with Alzheimer's.
These tests are the first objective tools that doctors have to help evaluate Alzheimer's, meaning that with a simple blood test, doctors and other health professionals allowed to order labs can get a clearer answers on Alzheimer's and its progression and get patients on a care plan earlier.
This will in fact give physicians a simple, objective test for Alzheimer's disease pathology that can help shorten the time to diagnosis.
Labcorp is the first company to make a fully blood-based ATN Profile commercially available.
What is ATN?
The ATN framework establishes a means for classifying biomarkers based on the biological evidence of Alzheimer's disease that each marker provides These markers are divided into three categories to reflect the three primary biological changes associated with Alzheimer's:
A for amyloid plaques: Accumulations of beta-amyloid 42 proteins begin to form plaques in the brain years before initial symptom onset
T for tau tangles: The beta-amyloid 42 accumulation causes misfolding of tau proteins, which tangle into knots and disrupt normal brain cell function
N for neurodegeneration: Brain cell functional impairment causes the cells to die, which exacerbates the characteristic cognitive impairment symptoms observed in Alzheimer's patients
Compliments from Labcorp
Does the ATN Profile diagnose Alzheimer's disease?
Biological confirmation of disease is necessary for diagnosis. This test provides evidence of the biological changes that are consistent with Alzheimer's disease. However, Alzheimer's still requires a clinical diagnosis based on clinical observation and cognitive testing.
How accurate is the test?
The ATN Profile was clinically validated using 200 samples from a well-studied cohort in which all samples were characterized with patient age, sex, amyloid PET status, and clinical diagnosis. The beta-amyloid 42/40 ratio assay showed a ROC analysis area under the curve (AUC) of 0.944, with a sensitivity of 96% and specificity of 86.7%.
Click Here is read White Paper on the ATN test
Labcorp Code: 484400
The current price for the test is $626.00 however, Labcorp is talking with health insurers, including the U.S. government's Medicare plan for people age 65 and over, about reimbursement terms for the test.
I highly recommend becoming familiar with Dr. Dale Bredesen's program called ReCode: https://www.apollohealthco.com/
It is the first proven program to Optimize Cognition and Reverse Dementia.
Alzheimer's and other forms of dementia is feared by our aging population however don't accept this dreaded diagnosis as an end all be all.
Most neurologists are simply not aware of the outstanding work of Dr. Dale Bredesen.
Here is the educational background behind the man who is changing the lives in a positive way for those suffering with Alzheimer's disease.
Dale Bredesen, M.D. is an expert in the mechanisms of neurodegenerative diseases such as Alzheimer's disease.
He received his undergraduate degree from Caltech and his medical degree from Duke University. He served as resident and chief resident in neurology at the University of California, San Francisco (UCSF) and as postdoctoral fellow in the laboratory of Nobel Laureate Professor Stanley Prusiner.
I will simply say that--- There is Hope..
** Always consult with a physician or healthcare practitioner with significant integrative or functional medicine training.
You can find a qualified and certified functional medicine practitioner by going to: www.FunctionalMedicineDoctors.com
The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Grisanti and his functional medicine community. Dr. Grisanti encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional. Visit www.FunctionalMedicineUniversity.com for more information on our training in functional medicine. Look for practitioners who have successfully completed the Functional Medicine University's Certification Program (CFMP) www.functionalmedicinedoctors.com. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Grisanti is required
Ronald Grisanti D.C., D.A.B.C.O., DACBN, MS, CFMP
Growing research has linked diabetes, exposure to air pollution, and alcohol as the top three modifiable contributors to the development of dementia.
Diabetes and Dementia
People with diabetes have about 60% increased risk of developing dementia compared to those without diabetes.
There are reasons that diabetes may affect dementia risk:
Some of the changes that occur in Alzheimer's disease are similar to those in diabetes. In both, nerve cells in the brain may become resistant to the effect of insulin. This may lead to the build-up of amyloid and tau proteins in the brain.
This relationship is so strong that some have called Alzheimer's “diabetes of the brain” or “type 3 diabetes (T3D)
Air Pollution and Dementia
More than 57 million people worldwide are currently living with dementia, and estimates suggest that number will increase to 153 million by 2050. Up to 40% of these cases are thought to be linked to potentially modifiable risk factors, such as exposure to air pollutants.
Exposure to a type of air pollution called fine particulate matter, or PM, has been identified as a potential risk factor for dementia.
An NIH-funded study published on August 14, 2023, in JAMA Internal Medicine led by Drs. Boya Zhang and Sara Adar from the University of Michigan examined the links between different types of PM air pollution and dementia. They looked at data from more than 27,000 adults aged 50 and older between 1992 and 2016.
As part of the study, participants underwent cognitive testing every two years or had caretakers report on their memory and cognitive function. The mean period of follow-up was 10.2 years. The average age of participants was 60.
The researchers estimated pollution exposures for the participants using models that included real-time pollution measurements and aspects of their homes like geography, land use, and local emissions sources.
The team found that 4,105 of the people studied approximately 15% developed dementia during the follow-up period.
Overall, higher PM exposure was linked to an increased risk of dementia. The team also examined nine specific sources of PM agriculture, road traffic, nonroad traffic, burning coal for energy, burning coal for industry, other energy production, other industry, wildfires, and windblown dust. After consideration of all sources from agriculture and wildfires were specifically associated with an increased risk of dementia.
The researchers estimated that, if PM exposure truly is a cause of cognitive decline and dementia, as many as 188,000 cases of dementia per year might be due to PM.
Alcohol and Dementia
Drinking alcohol is linked to reduced volume of the brain's white matter, which helps to transmit signals between different brain regions. This can lead to issues with the way the brain functions. Alcohol consumption above recommended limits (of 14 units per week) over a long period of time may shrink the parts of the brain involved in memory. Drinking more than 28 units per week can lead to a sharper decline in thinking skills as people get older.
Long-term heavy drinking can also result in a lack of vitamin B1 (thiamine) and Wernicke-Korsakoff syndrome which affects short-term memory.
Dr. Grisanti's Comments
When it comes to dementia, certain risk factors, such as aging and genetics, can't be changed. But other risk factors as discussed in this article (diabetes, air pollution and alcohol consumption) are modifiable, and knowing what they are can help you take steps to minimize their impact and protect your brain.
The results suggest that certain lifestyle changes could potentially help protect the brain from these risk factors. People can cut back on alcohol consumption, follow a plant-predominant diet/Mediterranean diet and exercise to prevent or reverse diabetes, and try to avoid situations where heavy air pollution is present.
I recommend the following three outstanding books on addressing and potentially reversing diabetes:
The End of Diabetes: The Eat to Live Plan to Prevent and Reverse Diabetes by Joel Fuhrman M.D.
Dr. Neal Barnard's Program for Reversing Diabetes: The Scientifically Proven System for Reversing Diabetes Without Drugs by Neal Barnard
Mastering Diabetes: The Revolutionary Method to Reverse Insulin Resistance Permanently in Type 1, Type 1.5, Type 2, Prediabetes, and Gestational Diabetes by Cyrus Khambatta PhD Robby Barbaro MPH
Here are my recommendations to improve indoor air quality and reduce PMs.
**I receive no compensation for recommending the following two air filter systems.
References:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5111529/
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2814924
https://www.sciencedirect.com/science/article/abs/pii/S1474442205702842
https://www.sciencedirect.com/science/article/abs/pii/S0014299904002110
https://www.nih.gov/news-events/nih-research-matters/air-pollution-linked-dementia-cases
https://pubmed.ncbi.nlm.nih.gov/30775976/
https://www.hsph.harvard.edu/news/press-releases/air-pollution-may-increase-risk-for-dementia/
https://www.bmj.com/content/381/bmj.p655
https://www.neurology.org/doi/10.1212/WNL.0000000000207656
https://pubmed.ncbi.nlm.nih.gov/15455646/
https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2800994
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957093/
https://www.nia.nih.gov/news/mind-and-mediterranean-diets-linked-fewer-signs-alzheimers-brain-pathology
https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-023-02772-3
https://content.iospress.com/articles/journal-of-alzheimers-disease/jad230418
https://www.sciencedirect.com/science/article/pii/S0002916523036079
https://onlinelibrary.wiley.com/doi/10.1002/mnfr.202100606
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9738978/
** Always consult with a physician or healthcare practitioner with significant integrative or functional medicine training before starting any of the above recommendations.
You can find a qualified and certified functional medicine practitioner by going to: www.FunctionalMedicineDoctors.com
The information on this website is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of Dr. Grisanti and his functional medicine community. Dr. Grisanti encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional. Visit www.FunctionalMedicineUniversity.com for more information on our training in functional medicine. Look for practitioners who have successfully completed the Functional Medicine University's Certification Program (CFMP) www.functionalmedicinedoctors.com. This content may be copied in full, with copyright, contact, creation and information intact, without specific permission, when used only in a not-for-profit format. If any other use is desired, permission in writing from Dr. Grisanti is required
Copyright © 2024 Dimensions of Wellness Healthcare - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.
Sign up to receive our colorful 6 Dimensions of Wellness Healthy Living Guide along with our blogs!